Cholinergic Enhancement of Theta

NCT07228338 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Epilepsy
Seizures
Cognitive Impairment, Mild
Memory Disorder
Memory Loss

Interventions

DRUG: COBENFY KarXT (50/20 mg)
DRUG: Placebo

Sponsor

University of Texas Southwestern Medical Center